Dabigo 150mg Capsule (Dabigatran Etexilate): A Comprehensive Overview
A drug known as Dabigo 150mg Capsule, which contains Dabigatran Etexilate as its active component, can be purchased online. It is administered quite frequently for the purpose of preventing and treating a wide variety of thromboembolic diseases because it is a member of the direct oral anticoagulants (DOACs) class of medications. In the following thorough explanation, we will supply you with important information regarding Dabigo 150mg Capsule, including its applications, recommended dosage, potential adverse effects, and safety measures.
Uses of Dabigo 150mg Capsule
The primary purpose of the Dabigo 150mg Capsule is to lessen the likelihood that patients with non-valvular atrial fibrillation (NVAF) would suffer from a stroke or a systemic embolism. NVAF refers to a condition that affects the heart and is characterised by an irregular heart beat. In addition, the Dabigo 150mg Capsule is recommended to patients who have recently undergone hip or knee replacement surgery for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Dabigo 150mg Capsule works to prevent the formation of blood clots by blocking the action of an enzyme called thrombin, which is involved in the process of clotting blood.
Dosage and Administration
The Dabigo 150mg Capsule should be taken orally twice daily at a dosage of 150mg. This is the suggested dosage. It is essential to ensure that the amount and length of therapy prescribed by your doctor are carried out in accordance with the directions supplied by your healthcare expert. The capsules should be taken with a full glass of water and should be swallowed whole. You can choose to take them with or without food.
If you forget to take a dose, you should take it as soon as you remember, unless it is getting close to the time of the following dose that you were supposed to take. In circumstances like these, it is best to ignore the missed dose and carry on with the dosing plan that you normally follow. It is not a good idea to take two doses at once in order to make up for a missed one.
Related Product
Dabigo 75mg Capsule
Dabigo 150mg Capsule
Side Effects
Although it is generally well accepted, Dabigo 150mg Capsule may cause certain undesirable side effects in some people. Symptoms of the gastrointestinal tract, such as indigestion, nausea, abdominal discomfort, and diarrhoea, are among the most often reported adverse effects. These adverse effects are often moderate in nature and short-lived.
Patients may in some instances have bleeding, which may show as nosebleeds, bruising, or prolonged bleeding from minor cuts. In other instances, patients may experience prolonged bleeding from minor injuries. It is essential to keep a close eye out for any indications of excessive bleeding and to seek immediate medical assistance in the event that severe bleeding or indications of an allergic response take place.
Precautions and Warnings
Before beginning treatment with Dabigo 150mg Capsule, you should discuss any preexisting medical concerns with your healthcare provider. These conditions may include problems with your liver or kidneys, blood disorders, or recent surgical procedures. This information will help your doctor decide whether or not Dabigo 150mg Capsule is appropriate for you, as well as how much of the medication you should take.
When treating individuals who are at a greater risk of bleeding, such as those who have a history of gastrointestinal bleeding or certain types of tumours, it is important to exercise extreme caution when administering Dabigo 150mg Capsule. It is essential to take the medication exactly as directed and to refrain from taking more than the suggested amount.
Because suddenly stopping therapy with Dabigo 150mg Capsule or making any other adjustments to your treatment plan can raise the chance of developing a blood clot, you should talk to your primary care physician before taking any of these actions.
Mechanism of Action
The active component of the Dabigo 150mg Capsule is called Dabigatran Etexilate. Etexilate of dabigatran is referred to as a prodrug since it is metabolised in the body to produce the active form of dabigatran. Because dabigatran is a direct thrombin inhibitor, this implies that it inhibits the activity of thrombin, an enzyme that is involved in the process of blood clotting, in a direct manner.
Because it inhibits thrombin, the Dabigo 150mg Capsule stops the transformation of fibrinogen into fibrin, which is an essential stage in the process of blood clot formation. This anticoagulant action helps lower the risk of stroke and systemic embolism in people who have non-valvular atrial fibrillation. It also helps patients who have had hip or knee replacement surgery avoid developing deep vein thrombosis and pulmonary embolism.
Drug Interactions
It is possible for Dabigo 150mg Capsule to interact with other drugs, which could decrease its effectiveness or raise the risk of bleeding if used together. You should let your doctor know about any and all medications you are currently taking, whether they are prescribed to you, available over-the-counter, or herbal supplements.
There is a possibility of drug interactions when taking Dabigo 150mg Capsule together with other medications, particularly antiplatelet pharmaceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), and other anticoagulants. Your physician will do an in-depth analysis of the possibility for adverse drug interactions and will change your treatment plan accordingly to minimise the risk to your health while maximising the benefits of the medicine.
Conclusion
Dabigo 150mg Capsule, also known as Dabigatran Etexilate, is a medicine that is frequently used for the prevention of and treatment of thromboembolic diseases. Some examples of these conditions include stroke, systemic embolism, deep vein thrombosis, and pulmonary embolism. If you are able to gain an awareness of the Dabigo 150mg Capsule’s uses, dose, potential adverse effects, and safety precautions, you will be able to utilise it efficiently and safely under the supervision of your healthcare professional. It is imperative that the correct dosage be taken as directed, that the approved administration instructions be followed, and that you speak with your healthcare professional to receive individualised guidance and assistance. You will be able to better control your illness and reduce the likelihood of experiencing problems related to thromboembolic events if you do so.
